FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2328142459> ?p ?o ?g. }

• W2328142459 endingPage "196" @default.
• W2328142459 startingPage "196" @default.
• W2328142459 abstract "INTRODUCTION: Male patients with prolactinoma commonly present with macroadenoma and a history of long-standing hypogonadism. Data regarding the effect of hypogonadism on bone health in these patients are scarce. The present study compared the long-term results of male patients with prolactinomas treated primarily either surgically or medically. METHODS: This retrospective study evaluated the records of 44 male patients with proven prolactinoma. Clinical and biochemical characteristics, as well as tumor size, were assessed at baseline and first and last follow-up. RESULTS: The mean age at diagnosis was 47 ± 15 years. Mean body mass index (BMI) at diagnosis was 28.7 ± 4.5 kg/m2. Median prolactin levels were 1979 μg/L (interquartile range [IQR] 768.4 5368), and MRI scan showed macro- or microadenoma in 82% and 18%, respectively. Pathological bone density was revealed in 25% of patients. Therapeutic strategy included primary operation in 34% and dopamine agonists in 66% of these patients. The average long-term follow-up was 81.4 ± 62.6 months. Mean body mass index tended to decrease, from 28.7 ± 4.5 to 28.0 ± 4.4 kg/m2 (P = .36). Median prolactin concentration decreased significantly to 13.8 μg/L (6.2 29.4) (IQR; P < .0001), and was within normal range in 73% of patients. Hyperprolactinaemia was controlled in 66% in the medically treated group vs 93% in the surgically treated group (P = .07). Control of hyperprolactinaemia required dopamine agonist therapy in 47% of patients with primary surgical therapy, compared to 90% of patients with primary medical therapy (P = .003). Fifty-five percent of all patients required testosterone therapy. Biphosphonate and/or vitamin D and calcium were prescribed in 29% of all patients, with no significant difference according to the therapeutic strategy (ie, primary surgery vs primary medical therapy; P = .16). CONCLUSION: Based on our results, bone densitometry in male patients with prolactinoma can be recommended. The present data support the discussion about the need for pituitary surgery as primary treatment in selected male patients aside from the classical indication (ie, intolerance of dopamine agonists and non-responder)." @default.
• W2328142459 created "2016-06-24" @default.
• W2328142459 creator A5000263730 @default.
• W2328142459 creator A5009322556 @default.
• W2328142459 creator A5011844380 @default.
• W2328142459 creator A5028116331 @default.
• W2328142459 creator A5068892157 @default.
• W2328142459 date "2014-08-01" @default.
• W2328142459 modified "2023-09-27" @default.
• W2328142459 title "Synthes Skull Base Surgery Award 113 Long-term Follow-up of Male Patients with Prolactinomas" @default.
• W2328142459 doi "https://doi.org/10.1227/01.neu.0000452387.71446.be" @default.
• W2328142459 hasPublicationYear "2014" @default.
• W2328142459 type Work @default.
• W2328142459 sameAs 2328142459 @default.
• W2328142459 citedByCount "0" @default.
• W2328142459 crossrefType "journal-article" @default.
• W2328142459 hasAuthorship W2328142459A5000263730 @default.
• W2328142459 hasAuthorship W2328142459A5009322556 @default.
• W2328142459 hasAuthorship W2328142459A5011844380 @default.
• W2328142459 hasAuthorship W2328142459A5028116331 @default.
• W2328142459 hasAuthorship W2328142459A5068892157 @default.
• W2328142459 hasConcept C119060515 @default.
• W2328142459 hasConcept C126322002 @default.
• W2328142459 hasConcept C126894567 @default.
• W2328142459 hasConcept C141071460 @default.
• W2328142459 hasConcept C167135981 @default.
• W2328142459 hasConcept C2778918492 @default.
• W2328142459 hasConcept C2779064019 @default.
• W2328142459 hasConcept C2779832395 @default.
• W2328142459 hasConcept C2780221984 @default.
• W2328142459 hasConcept C2781401123 @default.
• W2328142459 hasConcept C71315377 @default.
• W2328142459 hasConcept C71924100 @default.
• W2328142459 hasConceptScore W2328142459C119060515 @default.
• W2328142459 hasConceptScore W2328142459C126322002 @default.
• W2328142459 hasConceptScore W2328142459C126894567 @default.
• W2328142459 hasConceptScore W2328142459C141071460 @default.
• W2328142459 hasConceptScore W2328142459C167135981 @default.
• W2328142459 hasConceptScore W2328142459C2778918492 @default.
• W2328142459 hasConceptScore W2328142459C2779064019 @default.
• W2328142459 hasConceptScore W2328142459C2779832395 @default.
• W2328142459 hasConceptScore W2328142459C2780221984 @default.
• W2328142459 hasConceptScore W2328142459C2781401123 @default.
• W2328142459 hasConceptScore W2328142459C71315377 @default.
• W2328142459 hasConceptScore W2328142459C71924100 @default.
• W2328142459 hasIssue "Supplement 1" @default.
• W2328142459 hasLocation W23281424591 @default.
• W2328142459 hasOpenAccess W2328142459 @default.
• W2328142459 hasPrimaryLocation W23281424591 @default.
• W2328142459 hasRelatedWork W2018722598 @default.
• W2328142459 hasRelatedWork W2021147026 @default.
• W2328142459 hasRelatedWork W2073158788 @default.
• W2328142459 hasRelatedWork W2306893154 @default.
• W2328142459 hasRelatedWork W2763326319 @default.
• W2328142459 hasRelatedWork W3113707557 @default.
• W2328142459 hasRelatedWork W3148121872 @default.
• W2328142459 hasRelatedWork W4212912088 @default.
• W2328142459 hasRelatedWork W4236050785 @default.
• W2328142459 hasRelatedWork W4244952737 @default.
• W2328142459 hasVolume "61" @default.
• W2328142459 isParatext "false" @default.
• W2328142459 isRetracted "false" @default.
• W2328142459 magId "2328142459" @default.
• W2328142459 workType "article" @default.